Skip to Content
Series

Personalized drugs: How are they priced?

May 06, 2015 17:09 PM UTC
- Updated February 01, 2020 11:21 AM UTC

Fortune's Susie Gharib sits down with Novartis CEO Joseph Jimenez to talk about the company's advancements and what medicine personalization means for consumers.